Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Newsletter
Cancer Treatment, Global Warming Doublespeak and Counting All the Votes in NY
Shares of Dendreon Corp. rise as analysts look forward to new data on its experimental prostate cancer drug, Provenge. Public relations practitioners complain of scientists…
Newsletter
Cancer Drugs, Voting Rights and Cap and Trade Controversy
Author Virginia Postrel details her successful battle against breast cancer. The Justice Department re-considers whether the proposed D.C. voting rights bill is constitutional. States with…
Newsletter
Absurd Product Bans, Global Warming Legislation and Unsafe Organic Farming
Industry observers look to California to take the lead in ending the ban on online gambling. Reps. Henry Waxman and Ed Markey introduce sweeping new…
Op-Eds
Supreme Court Botches Preemption Case
SUPREME COURT BOTCHES PREEMPTION CASE…
Newsletter
AIG’s Tarnished Brand, The White House Vegetable Garden and Global Warming Negotiations
The damage to AIG’s corporate brand may hinder its ability to repay bailout loans from taxpayers. First Lady Michelle Obama announces the creation of a…
Op-Eds
Needle and the Damage Done
The Supreme Court botches a drug preemption case.